Children's Cancer and Leukaemia Group
Clinical Trials
Introduction to Clinical Trials

What is randomisation?

To avoid the risk of biased results, a patient can be randomly assigned to a form of treatment. This is essential in guaranteeing that there is no bias in the selection of patients for the different treatments but it must be properly conducted. The result of the two arms are kept blinded from participating clinicians while the study is ongoing, and will not be revealed until the end of the study.

It is not always possible to conduct randomised trials in paediatric oncology because of the rarity of the tumours, and the small numbers of available patients. In practice about one third of all UKCCSG trials will be randomised. The conduct of all is subject to close scrutiny by Independent Data Monitoring Committees.

>>>> How is a patient randomised for a particular trial? >>>>

  1. Introduction
  2. What is a Clinical Trial?
  3. Clinical Trial procedure
  4. The role of the Chief Investigator
  5. The Protocol
  6. How is the size of a clinical trial determined?
  7. What is a multi-centre trial?
  8. Role of coordinating centre/Trials Unit
  9. What is randomisation?
  10. How is a patient randomised for a particular trial?
  11. What is a control in clinical trials?
  12. Forms and data management
  13. Statistics in clinical trials
  1. The role of the trial coordinator
  2. Follow up
  3. How is the trial data analysed/evaluated?
  4. What are pharmacokinetic studies?
  5. Ethical issues
  6. Conduct of Clinical Trials/Research
  7. What is a blind trial?
  8. Interpretation and publication of findings
  9. Survival Curves
  10. CCLG Protocols – development and approval process
  11. References
  12. Download PDF